Observational analysis highlights inflammation regulation through long non-coding RNAs in immune response, suggesting new therapeutic pathways.
As part of the innate immune system, inflammation is a complex process that increases vascular permeability to eliminate pathogens and assist in the body’s healing process. Recently, the field of immunogenetics has identified long non-coding RNAs (lncRNAs) Gastric Adenocarcinoma Associated Positive CD44 Regulator Long Intergenic Non-Coding RNA (GAPLINC) and long intergenic non-coding RNA-Cyclooxygenase 2 (lincRNA-Cox2), with roles to regulate inflammation through the NK-kB pathway, transcription of immune genes, and macrophage activity. More specifically, GAPLINC regulates the translational ability of NF-κB subunit p65 and the functions of macrophages such as phagocytosis, antigen uptake, differentiation, and migration. On the other hand, lincRNA-Cox2 regulates the expression of proximal gene PTGS2 through an eRNA mechanism and acts as a scaffold for synthesizing the SWI/SNF complex.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: